Literature DB >> 33710363

[Machine learning and multiparametric MRI for early diagnosis of prostate cancer].

D Bonekamp1, H-P Schlemmer2.   

Abstract

In the last few years, the early diagnosis of prostate cancer has continued to shift from systematic biopsies to multiparametric MRI (mpMRI)-guided/MRI-transrectal ultrasound (TRUS) fusion biopsies and guidelines are already reflecting these changes. While MRI-TRUS fusion biopsies have already resulted in significant improvements in diagnostic sensitivity and, thus, correct diagnosis of clinically significant prostate cancer (sPC), its use to avoid biopsies in certain men is still controversial. Optimal use of mpMRI requires a high degree of reader expertise due to the difficulty of image interpretation and poses the problem of training sufficient numbers of radiologists while demand is increasing. Recently, artificial intelligence (AI) has been utilized to create fully automatic analysis tools for interpretation of mpMRI of the prostate, rivaling the performance of clinical radiologist interpretation in retrospective research studies, demonstrating the promising potential of AI for diagnostic prostate MRI in the future. This article will provide an overview of machine and deep learning and its application in mpMRI of the prostate for early diagnosis of prostate cancer.

Entities:  

Keywords:  Artificial intelligence; Decision-support techniques; Deep learning; Neural networks; Prostatic neoplasms

Mesh:

Year:  2021        PMID: 33710363     DOI: 10.1007/s00120-021-01492-x

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  15 in total

1.  Radiomic Machine Learning for Characterization of Prostate Lesions with MRI: Comparison to ADC Values.

Authors:  David Bonekamp; Simon Kohl; Manuel Wiesenfarth; Patrick Schelb; Jan Philipp Radtke; Michael Götz; Philipp Kickingereder; Kaneschka Yaqubi; Bertram Hitthaler; Nils Gählert; Tristan Anselm Kuder; Fenja Deister; Martin Freitag; Markus Hohenfellner; Boris A Hadaschik; Heinz-Peter Schlemmer; Klaus H Maier-Hein
Journal:  Radiology       Date:  2018-07-31       Impact factor: 11.105

Review 2.  Advancements in MR imaging of the prostate: from diagnosis to interventions.

Authors:  David Bonekamp; Michael A Jacobs; Riham El-Khouli; Dan Stoianovici; Katarzyna J Macura
Journal:  Radiographics       Date:  2011 May-Jun       Impact factor: 5.333

Review 3.  What Is the Negative Predictive Value of Multiparametric Magnetic Resonance Imaging in Excluding Prostate Cancer at Biopsy? A Systematic Review and Meta-analysis from the European Association of Urology Prostate Cancer Guidelines Panel.

Authors:  Paul C Moldovan; Thomas Van den Broeck; Richard Sylvester; Lorenzo Marconi; Joaquim Bellmunt; Roderick C N van den Bergh; Michel Bolla; Erik Briers; Marcus G Cumberbatch; Nicola Fossati; Tobias Gross; Ann M Henry; Steven Joniau; Theo H van der Kwast; Vsevolod B Matveev; Henk G van der Poel; Maria De Santis; Ivo G Schoots; Thomas Wiegel; Cathy Yuhong Yuan; Philip Cornford; Nicolas Mottet; Thomas B Lam; Olivier Rouvière
Journal:  Eur Urol       Date:  2017-03-21       Impact factor: 20.096

4.  Changes in morphology, infectivity and haemagglutinating activity of Semliki Forest virus produced by the treatment with caseinase C from Streptomyces albus G.

Authors:  P M Osterrieth; C M Calberg-Bacq
Journal:  J Gen Microbiol       Date:  1966-04

5.  PI-RADS Prostate Imaging - Reporting and Data System: 2015, Version 2.

Authors:  Jeffrey C Weinreb; Jelle O Barentsz; Peter L Choyke; Francois Cornud; Masoom A Haider; Katarzyna J Macura; Daniel Margolis; Mitchell D Schnall; Faina Shtern; Clare M Tempany; Harriet C Thoeny; Sadna Verma
Journal:  Eur Urol       Date:  2015-10-01       Impact factor: 20.096

6.  Prostate Magnetic Resonance Imaging, with or Without Magnetic Resonance Imaging-targeted Biopsy, and Systematic Biopsy for Detecting Prostate Cancer: A Cochrane Systematic Review and Meta-analysis.

Authors:  Frank-Jan H Drost; Daniel Osses; Daan Nieboer; Chris H Bangma; Ewout W Steyerberg; Monique J Roobol; Ivo G Schoots
Journal:  Eur Urol       Date:  2019-07-18       Impact factor: 20.096

7.  Classification of Cancer at Prostate MRI: Deep Learning versus Clinical PI-RADS Assessment.

Authors:  Patrick Schelb; Simon Kohl; Jan Philipp Radtke; Manuel Wiesenfarth; Philipp Kickingereder; Sebastian Bickelhaupt; Tristan Anselm Kuder; Albrecht Stenzinger; Markus Hohenfellner; Heinz-Peter Schlemmer; Klaus H Maier-Hein; David Bonekamp
Journal:  Radiology       Date:  2019-10-08       Impact factor: 11.105

8.  A review of computer-aided diagnosis in thoracic and colonic imaging.

Authors:  Kenji Suzuki
Journal:  Quant Imaging Med Surg       Date:  2012-09

9.  Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study.

Authors:  Hashim U Ahmed; Ahmed El-Shater Bosaily; Louise C Brown; Rhian Gabe; Richard Kaplan; Mahesh K Parmar; Yolanda Collaco-Moraes; Katie Ward; Richard G Hindley; Alex Freeman; Alex P Kirkham; Robert Oldroyd; Chris Parker; Mark Emberton
Journal:  Lancet       Date:  2017-01-20       Impact factor: 79.321

10.  MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis.

Authors:  Veeru Kasivisvanathan; Antti S Rannikko; Marcelo Borghi; Valeria Panebianco; Lance A Mynderse; Markku H Vaarala; Alberto Briganti; Lars Budäus; Giles Hellawell; Richard G Hindley; Monique J Roobol; Scott Eggener; Maneesh Ghei; Arnauld Villers; Franck Bladou; Geert M Villeirs; Jaspal Virdi; Silvan Boxler; Grégoire Robert; Paras B Singh; Wulphert Venderink; Boris A Hadaschik; Alain Ruffion; Jim C Hu; Daniel Margolis; Sébastien Crouzet; Laurence Klotz; Samir S Taneja; Peter Pinto; Inderbir Gill; Clare Allen; Francesco Giganti; Alex Freeman; Stephen Morris; Shonit Punwani; Norman R Williams; Chris Brew-Graves; Jonathan Deeks; Yemisi Takwoingi; Mark Emberton; Caroline M Moore
Journal:  N Engl J Med       Date:  2018-03-18       Impact factor: 176.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.